Study Cohort 1							Study Cohort 2							Control Group							P Valuea
	Mean	SD	Min	Q1	Med	Q3	Max	Mean	SD	Min	Q1	Med	Q3	Max	Mean	SD	Min	Q1	Med	Q3	Max	Study Cohort 1	Study Cohort 2
Hospitalizations
Total (18-45 y)	1.25	1.78	0	0	1	2	15	0.92	1.75	0	0	0	1	21	0.72	1.52	0	0	0	1	17	<.01	<.01
18-19 y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
20-26 y	1.13	1.64	0	0	1	2	12	0.90	1.64	0	0	0	1	10	0.69	1.64	0	0	0	1	17	<.01	.09
27-30 y	1.33	1.86	0	0	1	2	13	0.98	1.76	0	0	0	2	21	0.90	1.59	0	0	0	2	14	<.01	.44
31-35 y	1.32	1.81	0	0	1	2	14	1.12	1.80	0	0	0	2	18	0.82	1.49	0	0	0	1	11	<.01	<.01
36-40 y	1.15	1.66	0	0	1	2	12	0.79	1.89	0	0	0	1	20	0.61	1.58	0	0	0	1	17	<.01	.08
41-45 y	1.25	1.86	0	0	1	2	15	0.71	1.52	0	0	0	1	11	0.50	1.25	0	0	0	0	13	<.01	.02
Length of stay (days)
Total (18-45 y)	7.19	33.04	0	0	1	5	594	7.27	37.34	0	0	0	4	581	5.86	39.30	0	0	0	2	1008	.18	.17
18-19 y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
20-26 y	5.74	22.46	0	0	1	4	328	7.82	37.01	0	0	0	2	523	6.21	40.23	0	0	0	1	598	.85	.58
27-30 y	8.22	39.63	0	0	1	5	535	7.55	35.19	0	0	0	4	488	6.61	33.05	0	0	0	5	484	.45	.63
31-35 y	6.70	30.15	0	0	1	5	547	7.09	33.46	0	0	0	5	406	4.57	21.86	0	0	0	3	473	.11	.08
36-40 y	7.30	35.71	0	0	1	5	594	5.52	30.49	0	0	0	2	482	8.05	64.30	0	0	0	1	1008	.81	.39
41-45 y	7.64	31.59	0	0	1	5	395	9.05	51.64	0	0	0	2	581	4.08	24.79	0	0	0	0	415	.06	.06
Outpatient visits
Total (18-45 y)	43.23	26.19	0	25	37	53	234	38.60	26.16	0	21	33	50	224	32.07	33.88	0	14	25	41	696	<.01	<.01
18-19 y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
20-26 y	40.59	21.13	4	25	38	51	138	35.26	22.34	1	20	32	45	143	29.79	25.58	0	14	24	36	235	<.01	<.01
27-30 y	42.31	23.28	4	25	38	53	153	39.07	26.47	1	22	34	49	224	32.88	36.37	0	16	26	42	696	<.01	<.01
31-35 y	44.48	26.72	6	26	38	56	187	39.96	27.64	1	21	33	50	218	33.30	33.86	0	14	26	43	655	<.01	<.01
36-40 y	43.54	29.57	7	24	36	53	234	38.69	25.94	0	21	32	51	179	30.56	26.18	0	13	24	42	272	<.01	<.01
41-45 y	43.95	27.70	0	27	37	53	187	38.19	26.15	1	20	33	50	176	32.63	43.34	0	13	23	39	547	<.01	.02